Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Hologic ( (HOLX) ) is now available.
Hologic, Inc. has expanded its Board of Directors by appointing Martin Madaus, effective December 6, 2024. With over 30 years in diagnostics and life sciences, Madaus brings a wealth of experience from his roles at Carlyle Group and as CEO of Ortho Clinical Diagnostics and Millipore Corporation. This strategic addition aligns with Hologic’s commitment to enhancing leadership for future growth in women’s health technology.
See more insights into HOLX stock on TipRanks’ Stock Analysis page.